Broad-spectrum antiviral activity of adenosine analogues
Authors:
- Erik De ClercqErik De Clercq
- Donald E. BergstromDBDonald E. Bergstrom
- Antonin Holy JohnAJAntonin Holy John
- A. MontgomeryAMA. Montgomery
- 1 June 1984
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 4 (3) , 119-133
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed PatientsNew England Journal of Medicine, 1982
- Herpes Simplex EncephalitisNew England Journal of Medicine, 1981
- Anti-viral activity of 3-deazaadenosine and 5′-deoxy-5′-isobutylthio-3-deazaadenosine (3-deaza-SIBA)Biochemical and Biophysical Research Communications, 1981
- Virus Inhibitory Effect of Combination of 9-(S)-(2,3-Dihydroxypropyl) Adenine and 6-AzauridineChemotherapy, 1980
- 9‐(S)‐(2,3‐Dihydroxypropyl)adenine inhibits the transformation of chick embryo fibroblasts infected with rous sarcoma virusFEBS Letters, 1979
- Adenosylhomocysteine hydrolase inhibitors: Synthesis of 5′-deoxy-5′-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virusBiochemical and Biophysical Research Communications, 1978
- Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex EncephalitisNew England Journal of Medicine, 1977
- Effect of 5′‐deoxy‐5′‐S‐isobutyl adenosine on polyoma virus replicationFEBS Letters, 1976
- Inhibition of virus-induced cell transformation by synthetic analogues of S-adenosyl homocysteineBiochemical and Biophysical Research Communications, 1975
- Lentysine: A new hypolipidemic agent from a mushroomLife Sciences, 1970